AIM ImmunoTech Announces Addition of Single-Agent Ampligen Arm to Cancer Center's Ongoing Study in Cancer Patients with COVID-19

AIM ImmunoTech Announces Addition of Single-Agent Ampligen Arm to Cancer Center's Ongoing Study in Cancer Patients with COVID-19 

OCALA, Fla., March 22, 2021 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) today announced that the Institutional Review Board (IRB) of Roswell Park Comprehensive Cancer Center (Roswell Park) has approved a protocol amendment to Roswell Park's ongoing Phase 1/2a study evaluating the two-drug combination of AIM's Ampligen and interferon alpha-2b as a potential early-onset treatment for patients with cancer and mild-to-moderate COVID-19. The IRB-approved amendment calls for randomization of an additional twenty patients. Ten of these patients will receive a single dose of Ampligen, but no interferon treatment, and the other ten will receive best available care only. Ampligen alone has a generally well-tolerated safety profile with lower risk of adverse events than is generally expected with interferon therapy. "We are excited to see Ampligen tested not only as part of an antiviral treatment combination for COVID-19 among cancer patients, but also as a possible standalone therapy for this terrible virus," said AIM CEO Thomas K. Equels. "An early-onset treatment is especially critical for cancer patients, who face significantly increased risk of severe symptoms or death."


https://aimimmuno.irpass.com/ViewEmail.asp?b=2265&id=200459&p=2190717&I=1243298-K2r3p5x9n5


Popular Posts in the Last 7 Days

Scientific Ethics 101 for Louis Flamand

More evidence linking Chronic Fatigue Syndrome to the AIDS epidemic

Perplexity on the K.S. Revolution in AIDS Nosology and the HHV-8 Problem in Healthcare Workers

WTF?

A Letter on Justice and Open Debate

Perplexity writes a fantasy Joe Rogan interview with Rebecca Culshaw

An early paper that linked HHV-6 to Chronic Fatigue Syndrome

Popular Post in the Last 30 Days

Why Brigitte Huber may be the most important AIDS and Chronic Fatigue Syndrome researcher

How Kaposi's Sarcoma almost undermined the HIV theory of AIDS

Rebecca Culshaw Smith on a shocking new AIDS tragedy

HHV-6 is both "ubiquitous" and "remarkable."

Twenty Potential Mistakes Leading to the Misidentification of HIV as the Cause of AIDS

Popular Posts from the Last Year

Oral Kaposi's Sarcoma looks like the Crimson Crescents in Chronic Fatigue Syndrome patients.

Ablashi discusses HHV-6, AIDS, Alzheimer's, and Chronic Fatigue Syndrome

Why HIV should be referred to as "a red herring."

Anthony Fauci was part of the gang that silenced and destroyed Judy Mikovits.

Dr. Bhupesh Prusty and Professor Thomas Rudel discuss their HHV-6 research

All Time Most Popular Posts

Dr. Bhupesh Prusty and Professor Thomas Rudel discuss their HHV-6 research

Anthony Fauci was part of the gang that silenced and destroyed Judy Mikovits.

Was Judy Mikovits destroyed because her XMRV work would have ultimately shown HIV is a total fraud?

Is Chronic Fatigue Syndrome the other AIDS epidemic in the gay community?